New to Investment Firms?


Already have an account?

What Stocks Are This Week’s Biggest Gainers and Losers? – June 17, 2021

The top gainers and losers list provides a summary about which stocks are performing well for the past week. This can give a good snapshot in time of some of the companies that are doing the best, and some that are not doing so well.

The stocks that gained and lost the most on June 15, 2021 can be seen below.

Top Gaining Stocks for This Week

Here are the stocks with the biggest rise in stock price for this week.

1. Orphazyme – Up 64.38%

Orphazyme (ORPH). They develop cutting-edge therapies for patients suffering from uncommon neurodegenerative illnesses. Their research focuses on using HSP70’s cell-protective characteristics to develop novel treatments for uncommon neurodegenerative disorders.

2. Arrival – Up 21.85%

Arrival (ARVLW). They manufacture commercial electric cars for use in the United Kingdom, the United States, and other parts of the world. Arrival’s outstanding technology and production skills will further impact the business in the future.

3. Opthea – Up 21.08%

Opthea (OPT). They are dedicated to helping individuals with retinal eye disorders see better. Opthea (NASDAQ:OPT) stock is up 41% in afternoon trade, presumably as a result of Clearside Biomedical’s data release yesterday.

4. Altimmune, Inc. – Up 16.49%

Altimmune, Inc. (ALT). They are a biopharmaceutical firm in the early stages of development that focuses on liver disease treatments and immune modifying medicines. After positive results for a weight-loss drug candidate, Altimmune’s stock rose 17%.

5. Arcimoto Inc. – Up 16.3%

Arcimoto Inc (FUV). They are an automobile company that focuses on building the SRK, a three-wheeled electric vehicle. The company makes tools that aid in the transition towards a more sustainable transportation system.

Top Losing Stocks for This Week

Here are the stocks with the biggest dip in stock price for this week.

1. 9F Inc. – Down 14.29%

9F Inc. (JFU). They are an internet technology firm that specializes in fintech and online wealth management technologies. The company provides a digital financial accounting platform that allows customers to customize and integrate solutions.

2. Fusion Pharmaceuticals Inc. – Down 13.59 %

Fusion Pharmaceuticals Inc (FUSN). They are a clinical-stage biopharmaceutical firm dedicated to the development of cancer-curing tailored alpha therapies. Fusion is aggressively in-licensing targeted compounds and developing strategic collaborations to develop its pipeline of cancer treatments

3. Uxin Limited – Down 12.64%

Uxin Limited (UXIN). They are a Chinese holding corporation headquartered in Beijing. The firm provides used vehicle e-commerce platforms through mobile apps and websites.

4. Paratek Pharmaceuticals, Inc. – Down 11.78%

Paratek Pharmaceuticals, Inc. (PRTK). They are a commercial-stage biopharmaceutical business that develops and commercializes innovative life-saving treatments for life-threatening illnesses.

After the firm announced the opening of clinical trial sites for its Phase 2b research, Paratek Pharmaceuticals Inc. shares fell 16 percent to $8.56 on Wednesday.

5. Intellia Therapeutics, Inc. – Down 10.19%

Intellia Therapeutics, Inc. (NTLA). They are working on a groundbreaking genome editing therapy to treat hereditary disorders. Novartis and Regeneron have even partnered with the firm.

Should You Invest in the Top Stocks?

Before making any investments, investors should look at financial information about the company, its industry, and the market as a whole. If you’re interested in learning more about investing in the top stocks, you should speak with a financial advisor today.